Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Eckstein

Showing results (61-70 of 262) with videos related to

Pageof 27
Sort By:
Human Pathology|June 9, 2018
DICER1 mutation-positive giant botryoid fibroepithelial polyp of the urinary bladder mimicking embryonal rhabdomyosarcomaMarkus Eckstein, Abbas Agaimy, Joachim Woenckhaus, et al.
Pathology Oncology Research : POR|September 12, 2019
Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC)Philipp J Spachmann, Vanessa Azzolina, Florian Weber, et al.
Journal for Immunotherapy of Cancer|October 3, 2025
Spatial transcriptomic profiling of metastatic renal cell carcinoma identifies chemokine-driven macrophage and CD8+ T-cell interactions predictive of immunotherapy responseCharis Kalogirou, Markus Krebs, Andreas S Kunz, et al.
Cancers|March 6, 2021
Tumour-Infiltrating Lymphocytes (TILs) and PD-L1 Expression Correlate with Lymph Node Metastasis, High-Grade Transformation and Shorter Metastasis-Free Survival in Patients with Acinic Cell Carcinoma (AciCC) of the Salivary GlandsSelina Hiss, Markus Eckstein, Patricia Segschneider, et al.
Urologie (Heidelberg, Germany)|August 1, 2023
[Individualized precision medicine]Bernd Wullich, Helge Taubert, Peter J Goebell, et al.
Scientific Reports|September 10, 2021
Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancerMarkus Eckstein, Charlotte Kimmel, Johannes Bruendl, et al.
Oncotarget|June 15, 2018
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screeningSebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 18, 2020
Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancerSheng Wu, Katja Nitschke, Thomas Stefan Worst, et al.
Inflammatory Bowel Diseases|October 29, 2025
Quantitative Analysis of Distinct Colon Crypt Branching Modes Using Interpretable Machine LearningDaniel Firmbach, Corinna Lang-Schwarz, Carlos A Rubio, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2024
High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinomaNiklas Klümper, Alexander Cox, Markus Eckstein, et al.
Pageof 27

Showing results (61-70 of 262) with videos related to

Sort By:
Pageof 27
Human Pathology|June 9, 2018
DICER1 mutation-positive giant botryoid fibroepithelial polyp of the urinary bladder mimicking embryonal rhabdomyosarcomaMarkus Eckstein, Abbas Agaimy, Joachim Woenckhaus, et al.
Pathology Oncology Research : POR|September 12, 2019
Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC)Philipp J Spachmann, Vanessa Azzolina, Florian Weber, et al.
Journal for Immunotherapy of Cancer|October 3, 2025
Spatial transcriptomic profiling of metastatic renal cell carcinoma identifies chemokine-driven macrophage and CD8+ T-cell interactions predictive of immunotherapy responseCharis Kalogirou, Markus Krebs, Andreas S Kunz, et al.
Cancers|March 6, 2021
Tumour-Infiltrating Lymphocytes (TILs) and PD-L1 Expression Correlate with Lymph Node Metastasis, High-Grade Transformation and Shorter Metastasis-Free Survival in Patients with Acinic Cell Carcinoma (AciCC) of the Salivary GlandsSelina Hiss, Markus Eckstein, Patricia Segschneider, et al.
Urologie (Heidelberg, Germany)|August 1, 2023
[Individualized precision medicine]Bernd Wullich, Helge Taubert, Peter J Goebell, et al.
Scientific Reports|September 10, 2021
Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancerMarkus Eckstein, Charlotte Kimmel, Johannes Bruendl, et al.
Oncotarget|June 15, 2018
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screeningSebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 18, 2020
Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancerSheng Wu, Katja Nitschke, Thomas Stefan Worst, et al.
Inflammatory Bowel Diseases|October 29, 2025
Quantitative Analysis of Distinct Colon Crypt Branching Modes Using Interpretable Machine LearningDaniel Firmbach, Corinna Lang-Schwarz, Carlos A Rubio, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2024
High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinomaNiklas Klümper, Alexander Cox, Markus Eckstein, et al.
Pageof 27